Currently the price is 108,13$, In this post we are going to talk about the listed company Blueprint Medicines Corp, its leaders are Becker Hewes (Chief Medical Officer), Fouad Namouni (President-Research & Development), Jeffrey W. Albers (President, Chief Executive Officer & Director), Kathryn Haviland (Chief Operating Officer), Michael Landsittel (Chief Financial Officer), Percy H. Carter (Chief Scientific Officer), they lead it to work in Biotechnology: Pharmaceutical Preparations especially in the North America region.
The closing price of the stock yesterday was desconocido$.
With an intraday difference of 107,75$ moving between 106,01$ and 109,48$, it is a notable difference that allows quick purchases and sales.
Their latest annual data shows an income of desconocido.
The last value we have registered for the opening is desconocido.
To detect if it is a good time to enter or exit a stock, many traders use the lowest and highest values of the last 52 weeks. In this action, prices have moved between 0,00$ and 0,00$.
The EPS, or net profit divided by the number of shares in progress, tells us with a high value that we must enter and with a low value that we must leave, it is a result of how the company has done in the last year.
Buscar
